Understanding the cellular and molecular mediators of adipose inflammation offers critical insight into the pathogenesis of obesity-related metabolic disease and highlights potential therapeutic targets for restoring insulin sensitivity (Figure 2). This evidence concerns the gene INS and metabolic disease.